BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 21629196)

  • 1. Modulation of vitamin D signaling is a potential therapeutic target to lower cardiovascular risk in chronic kidney disease.
    Hu P; Hu B; Wang J; Lu L; Qin YH
    Med Sci Monit; 2011 Jun; 17(6):HY14-20. PubMed ID: 21629196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor-23 helps explain the biphasic cardiovascular effects of vitamin D in chronic kidney disease.
    Hu P; Xuan Q; Hu B; Lu L; Wang J; Qin YH
    Int J Biol Sci; 2012; 8(5):663-71. PubMed ID: 22606047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can vitamin D deficiency cause diabetes and cardiovascular diseases? Present evidence and future perspectives.
    Muscogiuri G; Sorice GP; Ajjan R; Mezza T; Pilz S; Prioletta A; Scragg R; Volpe SL; Witham MD; Giaccari A
    Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):81-7. PubMed ID: 22265795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D and the cardiovascular system.
    Artaza JN; Mehrotra R; Norris KC
    Clin J Am Soc Nephrol; 2009 Sep; 4(9):1515-22. PubMed ID: 19696220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D Deficiency and Supplementation in Cardiovascular Disorders.
    Mihos CG; De La Cruz JA; Hernandez A; Santana O
    Cardiol Rev; 2017; 25(4):189-196. PubMed ID: 28574937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypovitaminosis D in chronic kidney disease patients: prevalence and treatment.
    Cuppari L; Garcia-Lopes MG
    J Ren Nutr; 2009 Jan; 19(1):38-43. PubMed ID: 19121769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of diabetes mellitus on vitamin D metabolism in predialysis patients.
    Tanaka H; Hamano T; Fujii N; Tomida K; Matsui I; Mikami S; Nagasawa Y; Ito T; Moriyama T; Horio M; Imai E; Isaka Y; Rakugi H
    Bone; 2009 Nov; 45(5):949-55. PubMed ID: 19631779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic Acid and Vitamin B12 Administration in CKD, Why Not?
    Capelli I; Cianciolo G; Gasperoni L; Zappulo F; Tondolo F; Cappuccilli M; La Manna G
    Nutrients; 2019 Feb; 11(2):. PubMed ID: 30781775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extra-skeletal effects of vitamin D deficiency in chronic kidney disease.
    Chonchol M; Kendrick J; Targher G
    Ann Med; 2011 Jun; 43(4):273-82. PubMed ID: 21214426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease?
    Levin A; Li YC
    Kidney Int; 2005 Nov; 68(5):1973-81. PubMed ID: 16221197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D and Cardiovascular Risk: which Implications in Children?
    Savastio S; Pozzi E; Tagliaferri F; Degrandi R; Cinquatti R; Rabbone I; Bona G
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular disease and its relationship with chronic kidney disease.
    Liu M; Li XC; Lu L; Cao Y; Sun RR; Chen S; Zhang PY
    Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2918-26. PubMed ID: 25339487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Con: Nutritional vitamin D replacement in chronic kidney disease and end-stage renal disease.
    Agarwal R; Georgianos PI
    Nephrol Dial Transplant; 2016 May; 31(5):706-13. PubMed ID: 27190392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D supplementation in CKD.
    Martin KJ; González EA
    Clin Nephrol; 2011 Apr; 75(4):286-93. PubMed ID: 21426882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypovitaminosis D is associated with endothelial dysfunction in patients with non-dialysis chronic kidney disease.
    Zhang QY; Jiang CM; Sun C; Tang TF; Jin B; Cao DW; He JS; Zhang M
    J Nephrol; 2015 Aug; 28(4):471-6. PubMed ID: 25515034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential for vitamin D receptor agonists in the treatment of cardiovascular disease.
    Wu-Wong JR
    Br J Pharmacol; 2009 Sep; 158(2):395-412. PubMed ID: 19371337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty Liver and Chronic Kidney Disease: Novel Mechanistic Insights and Therapeutic Opportunities.
    Musso G; Cassader M; Cohney S; De Michieli F; Pinach S; Saba F; Gambino R
    Diabetes Care; 2016 Oct; 39(10):1830-45. PubMed ID: 27660122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary hyperparathyroidism in chronic kidney disease: focus on clinical consequences and vitamin D therapies.
    Hudson JQ
    Ann Pharmacother; 2006 Sep; 40(9):1584-93. PubMed ID: 16912241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vitamin D deficiency in CKD patients].
    Hamano T
    Clin Calcium; 2007 May; 17(5):718-24. PubMed ID: 17471001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular disease in chronic kidney failure: is there a role for vitamin D analogs?
    Wu-Wong JR; Nakane M; Traylor L; Ruan X; Kroeger PE; Tian J
    Curr Opin Investig Drugs; 2005 Mar; 6(3):245-54. PubMed ID: 15816500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.